The R1275Q Neuroblastoma Mutant and Certain ATP-competitive Inhibitors Stabilize Alternative Activation Loop Conformations of Anaplastic Lymphoma Kinase
- Amgen
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- INDUSTRY
- OSTI ID:
- 1086337
- Journal Information:
- J. Biol. Chem., Vol. 287, Issue (44) ; 10, 2012
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer
The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer
Journal Article
·
Wed Aug 03 00:00:00 EDT 2011
· Journal of Medicinal Chemistry
·
OSTI ID:1086337
+22 more
The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer
Journal Article
·
Wed Sep 18 00:00:00 EDT 2013
· J. Med. Chem.
·
OSTI ID:1086337
+17 more
The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer
Journal Article
·
Tue Jul 10 00:00:00 EDT 2012
· Journal of Medicinal Chemistry
·
OSTI ID:1086337
+17 more